{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T10:26:20Z","timestamp":1793787980471,"version":"4.6.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T00:00:00Z","timestamp":1758499200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T00:00:00Z","timestamp":1758499200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100015988","name":"National Institute for Research in Tuberculosis","doi-asserted-by":"publisher","award":["Fellowship\/Bact\/RA\/Padmasini\/31.10.2022"],"award-info":[{"award-number":["Fellowship\/Bact\/RA\/Padmasini\/31.10.2022"]}],"id":[{"id":"10.13039\/501100015988","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015988","name":"National Institute for Research in Tuberculosis","doi-asserted-by":"publisher","award":["F.No. 3\/1\/3\/PDF(21)\/2019-HRD dt 18.03.2020"],"award-info":[{"award-number":["F.No. 3\/1\/3\/PDF(21)\/2019-HRD dt 18.03.2020"]}],"id":[{"id":"10.13039\/501100015988","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015988","name":"National Institute for Research in Tuberculosis","doi-asserted-by":"publisher","award":["No. Fellowship\/TB\/40\/2020-7030"],"award-info":[{"award-number":["No. Fellowship\/TB\/40\/2020-7030"]}],"id":[{"id":"10.13039\/501100015988","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Folia Microbiol"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s12223-025-01319-8","type":"journal-article","created":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T01:34:30Z","timestamp":1758504870000},"page":"1385-1396","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Flurbiprofen restores rifampicin and isoniazid sensitivity in multidrug-resistant Mycobacterium tuberculosis putatively by inhibiting efflux pumps Rv0194 and Rv0933"],"prefix":"10.1007","volume":"71","author":[{"given":"Padmasini","family":"Elango","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christy Rosaline","family":"Nirmal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam Ebenezer","family":"Rajadas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajkumar","family":"Ravi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naresh Babu","family":"Chilamakuru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azger Dusthackeer","family":"V. N.","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,22]]},"reference":[{"key":"1319_CR1","doi-asserted-by":"publisher","unstructured":"Amaral RCRd, Caleffi-Ferracioli KR, Demitto FdO et al (2020) Is the efflux pump inhibitor Verapamil a potential booster for isoniazid against Mycobacterium tuberculosis? Braz J Pharm Sci 56. https:\/\/doi.org\/10.1590\/s2175-97902020000218309","DOI":"10.1590\/s2175-97902020000218309"},{"key":"1319_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcab.2024.103381","volume":"61","author":"SS Biswas","year":"2024","unstructured":"Biswas SS, Roy JD (2024) Prediction of structure of mycobacterial efflux pump protein Rv0194 and molecular dynamics simulation of the predicted structures. Biocatal Agric Biotechnol 61:103381. https:\/\/doi.org\/10.1016\/j.bcab.2024.103381","journal-title":"Biocatal Agric Biotechnol"},{"key":"1319_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2020.119076","volume":"578","author":"S Caban-Toktas","year":"2020","unstructured":"Caban-Toktas S, Sahin A, Lule S et al (2020) Combination of paclitaxel and R-flurbiprofen loaded PLGA nanoparticles suppresses glioblastoma growth on systemic administration. Int J Pharm 578:119076. https:\/\/doi.org\/10.1016\/j.ijpharm.2020.119076","journal-title":"Int J Pharm"},{"key":"1319_CR4","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1128\/AAC.00298-08","volume":"52","author":"O Danilchanka","year":"2008","unstructured":"Danilchanka O, Mailaender C, Niederweis M (2008) Identification of a novel multidrug efflux pump of Mycobacterium tuberculosis. Antimicrob Agents Chemother 52:2503\u20132511. https:\/\/doi.org\/10.1128\/AAC.00298-08","journal-title":"Antimicrob Agents Chemother"},{"key":"1319_CR5","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1097\/QCO.0000000000000899","volume":"36","author":"GR Davies","year":"2023","unstructured":"Davies GR, Aston S (2023) Update on drug treatments for multidrug resistant tuberculosis. Curr Opin Infect Dis 36:132\u2013139. https:\/\/doi.org\/10.1097\/QCO.0000000000000899","journal-title":"Curr Opin Infect Dis"},{"key":"1319_CR6","doi-asserted-by":"publisher","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","volume":"58","author":"V De Pires","year":"2015","unstructured":"De Pires V, Blundell TL, Ascher DB (2015) pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. J Med Chem 58:4066\u20134072. https:\/\/doi.org\/10.1021\/acs.jmedchem.5b00104","journal-title":"J Med Chem"},{"key":"1319_CR7","doi-asserted-by":"publisher","first-page":"591","DOI":"10.5588\/ijtld.19.0458","volume":"24","author":"JVP de Souza","year":"2020","unstructured":"de Souza JVP, Murase LS, Caleffi-Ferracioli KR et al (2020) Isoniazid and verapamil modulatory activity and efflux pump gene expression in Mycobacterium tuberculosis. Int J Tuberc Lung Dis 24:591\u2013596. https:\/\/doi.org\/10.5588\/ijtld.19.0458","journal-title":"Int J Tuberc Lung Dis"},{"key":"1319_CR8","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1021\/acsinfecdis.4c00091","volume":"10","author":"M Duffey","year":"2024","unstructured":"Duffey M, Jumde RP, da Costa RMA et al (2024) Extending the potency and lifespan of antibiotics: inhibitors of gram-negative bacterial efflux pumps. ACS Infect Dis 10:1458\u20131482. https:\/\/doi.org\/10.1021\/acsinfecdis.4c00091","journal-title":"ACS Infect Dis"},{"key":"1319_CR9","doi-asserted-by":"publisher","first-page":"13248","DOI":"10.1038\/s41598-022-17524-1","volume":"12","author":"L Guan","year":"2022","unstructured":"Guan L (2022) Structure and mechanism of membrane transporters. Sci Rep 12:13248. https:\/\/doi.org\/10.1038\/s41598-022-17524-1","journal-title":"Sci Rep"},{"key":"1319_CR10","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2013-002672","volume":"3","author":"JD Guzman","year":"2013","unstructured":"Guzman JD, Evangelopoulos D, Gupta A et al (2013) Antitubercular specific activity of ibuprofen and the other 2-arylpropanoic acids using the HT-SPOTi whole-cell phenotypic assay. BMJ Open 3:e002672. https:\/\/doi.org\/10.1136\/bmjopen-2013-002672","journal-title":"BMJ Open"},{"key":"1319_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26092811","volume":"26","author":"D Iacopetta","year":"2021","unstructured":"Iacopetta D, Catalano A, Ceramella J et al (2021) The different facets of triclocarban: a review. Molecules 26:2811. https:\/\/doi.org\/10.3390\/molecules26092811","journal-title":"Molecules"},{"key":"1319_CR12","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1021\/ci049714+","volume":"45","author":"JJ Irwin","year":"2005","unstructured":"Irwin JJ, Shoichet BK (2005) ZINC\u2013a free database of commercially available compounds for virtual screening. J Chem Inf Model 45:177\u2013182. https:\/\/doi.org\/10.1021\/ci049714+","journal-title":"J Chem Inf Model"},{"key":"1319_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/molecules29020385","volume":"29","author":"I Ivanov","year":"2024","unstructured":"Ivanov I, Manolov S, Bojilov D et al (2024) Novel flurbiprofen derivatives as antioxidant and anti-inflammatory agents: synthesis, in silico, and in vitro biological evaluation. Molecules 29:385. https:\/\/doi.org\/10.3390\/molecules29020385","journal-title":"Molecules"},{"key":"1319_CR14","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1021\/ar000033j","volume":"33","author":"PA Kollman","year":"2000","unstructured":"Kollman PA, Massova I, Reyes C et al (2000) Calculating structures and free energies of complex molecules: combining molecular mechanics and continuum models. Acc Chem Res 33:889\u2013897. https:\/\/doi.org\/10.1021\/ar000033j","journal-title":"Acc Chem Res"},{"key":"1319_CR15","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/ja.2015.9","volume":"68","author":"G Li","year":"2015","unstructured":"Li G, Zhang J, Guo Q et al (2015) Study of efflux pump gene expression in rifampicin-monoresistant Mycobacterium tuberculosis clinical isolates. J Antibiot (Tokyo) 68:431\u2013435. https:\/\/doi.org\/10.1038\/ja.2015.9","journal-title":"J Antibiot (Tokyo)"},{"key":"1319_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2021\/8899674","volume":"2021","author":"Y Lin","year":"2021","unstructured":"Lin Y, Dong Y, Gao Y et al (2021) Identification of CTL epitopes on efflux pumps of the ATP-binding cassette and the major facilitator superfamily of Mycobacterium tuberculosis. J Immunol Res 2021:1\u201313. https:\/\/doi.org\/10.1155\/2021\/8899674","journal-title":"J Immunol Res"},{"key":"1319_CR17","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","volume":"46","author":"CA Lipinski","year":"2001","unstructured":"Lipinski CA, Lombardo F, Dominy BW, Feeney PJ (2001) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 46:3\u201326. https:\/\/doi.org\/10.1016\/S0169-409X(00)00129-0","journal-title":"Adv Drug Deliv Rev"},{"key":"1319_CR18","doi-asserted-by":"publisher","unstructured":"Long Y, Wang B, Xie T et al (2024) Overexpression of efflux pump genes is one of the mechanisms causing drug resistance in Mycobacterium tuberculosis. Microbiol Spectr 12. https:\/\/doi.org\/10.1128\/spectrum.02510-23","DOI":"10.1128\/spectrum.02510-23"},{"key":"1319_CR19","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1002\/jcc.21256","volume":"30","author":"GM Morris","year":"2009","unstructured":"Morris GM, Huey R, Lindstrom W et al (2009) AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J Comput Chem 30:2785\u20132791. https:\/\/doi.org\/10.1002\/jcc.21256","journal-title":"J Comput Chem"},{"key":"1319_CR20","doi-asserted-by":"publisher","first-page":"192","DOI":"10.4103\/ijmr.ijmr_1610_22","volume":"157","author":"CR Nirmal","year":"2023","unstructured":"Nirmal CR, Rajadas SE, Balasubramanian M et al (2023) Dodecanoic acid & palmitic acid disarms rifampicin resistance by putatively targeting mycobacterial efflux pump Rv1218c. Indian J Med Res 157:192\u2013203. https:\/\/doi.org\/10.4103\/ijmr.ijmr_1610_22","journal-title":"Indian J Med Res"},{"key":"1319_CR21","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1111\/cbdd.14197","volume":"101","author":"CR Nirmal","year":"2023","unstructured":"Nirmal CR, Rajadas SE, Balasubramanian M et al (2023) Myoinositol and methyl stearate increases rifampicin susceptibility among drug-resistant Mycobacterium tuberculosis expressing Rv1819c. Chem Biol Drug des 101:883\u2013895. https:\/\/doi.org\/10.1111\/cbdd.14197","journal-title":"Chem Biol Drug des"},{"key":"1319_CR22","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1093\/jac\/dkv316","volume":"71","author":"CM Pule","year":"2016","unstructured":"Pule CM, Sampson SL, Warren RM et al (2016) Efflux pump inhibitors: targeting mycobacterial efflux systems to enhance TB therapy. J Antimicrob Chemother 71:17\u201326. https:\/\/doi.org\/10.1093\/jac\/dkv316","journal-title":"J Antimicrob Chemother"},{"key":"1319_CR23","doi-asserted-by":"publisher","DOI":"10.1093\/femsre\/fuab050","volume":"46","author":"S Remm","year":"2022","unstructured":"Remm S, Earp JC, Dick T et al (2022) Critical discussion on drug efflux in Mycobacterium tuberculosis. FEMS Microbiol Rev 46:fuab050. https:\/\/doi.org\/10.1093\/femsre\/fuab050","journal-title":"FEMS Microbiol Rev"},{"key":"1319_CR24","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s10822-007-9133-z","volume":"21","author":"JC Shelley","year":"2007","unstructured":"Shelley JC, Cholleti A, Frye LL et al (2007) Epik: a software program for pK a prediction and protonation state generation for drug-like molecules. J Comput Aided Mol des 21:681\u2013691. https:\/\/doi.org\/10.1007\/s10822-007-9133-z","journal-title":"J Comput Aided Mol des"},{"key":"1319_CR25","doi-asserted-by":"publisher","DOI":"10.1002\/cmdc.202400018","volume":"20","author":"S Sonam","year":"2025","unstructured":"Sonam S, Jela\u010da S, Laube M et al (2025) Carborane conjugates with ibuprofen, fenoprofen and flurbiprofen: synthesis, characterization, COX inhibition potential and in vitro activity. Chem Med Chem 20:e202400018. https:\/\/doi.org\/10.1002\/cmdc.202400018","journal-title":"Chem Med Chem"},{"key":"1319_CR26","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1039\/D0MD00422G","volume":"12","author":"JP Soni","year":"2021","unstructured":"Soni JP, Yeole Y, Shankaraiah N (2021) \u03b2-Carboline-based molecular hybrids as anticancer agents: a brief sketch. RSC Med Chem 12:730\u2013750. https:\/\/doi.org\/10.1039\/D0MD00422G","journal-title":"RSC Med Chem"},{"key":"1319_CR27","doi-asserted-by":"publisher","unstructured":"Valentovic M (2007) Flurbiprofen. In: Enna S J, Bylund DB (eds) xPharm: The Comprehensive Pharmacology Reference. Elsevier, pp 1\u20136.\u00a0https:\/\/doi.org\/10.1016\/B978-008055232-3.61777-5","DOI":"10.1016\/B978-008055232-3.61777-5"},{"key":"1319_CR28","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1080\/1120009X.2023.2173857","volume":"35","author":"G Val\u0131yeva","year":"2023","unstructured":"Val\u0131yeva G, Durup\u0131nar B, Coban AY (2023) Efflux pump effects on Mycobacterium tuberculosis drug resistance. J Chemother 35:601\u2013609. https:\/\/doi.org\/10.1080\/1120009X.2023.2173857","journal-title":"J Chemother"},{"key":"1319_CR29","unstructured":"Global Tuberculosis Programme (2023) Global tuberculosis report - 2023. World Health Organization, Geneva"},{"key":"1319_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-9-40","volume":"9","author":"Y Zhang","year":"2008","unstructured":"Zhang Y (2008) I-TASSER server for protein 3D structure prediction. BMC Bioinformatics 9:40. https:\/\/doi.org\/10.1186\/1471-2105-9-40","journal-title":"BMC Bioinformatics"}],"container-title":["Folia Microbiologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12223-025-01319-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12223-025-01319-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12223-025-01319-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T09:40:26Z","timestamp":1793785226000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12223-025-01319-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,22]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["1319"],"URL":"https:\/\/doi.org\/10.1007\/s12223-025-01319-8","relation":{},"ISSN":["0015-5632","1874-9356"],"issn-type":[{"value":"0015-5632","type":"print"},{"value":"1874-9356","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,22]]},"assertion":[{"value":"28 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Institutional Ethics Committee of the ICMR-National Institute for Research in Tuberculosis (NIRT, Chennai) before its implementation (No: 021\/NIRT-IEC\/2021; dtd 25\/2\/2021).This study was also submitted and issued approval from the institutional bioethics committee for Category III as per the guidelines of DBT held at ICMR NIRT, Chennai, on 06\/10\/2021.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}